Home › Endometrial Cancer › South Carolina › Greenville
Endometrial Cancer clinical trials in Greenville, SC
5 studies for Endometrial Cancer are looking for participants at sites in and around Greenville (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
Targeted Therapy Directed by Genetic Testing in Treating Patients With Locally Advanced or Advanced Solid Tumors, The ComboMATCH Screening Trial
RecruitingPhase 2
- Saint Francis Hospital, Greenville
- BI-LO Charities Children's Cancer Center, Greenville
- Prisma Health Cancer Institute - Butternut, Greenville
- and 3 more
A Phase 1 Study of the Safety and Tolerability of CTX-10726
RecruitingPhase 1
- Prisma Health Cancer Institute, Greenville
Evaluate BL-B01D1 in Patients With Metastatic or Unresectable Non-Small Cell Lung Cancer (NSCLC) and Other Solid Tumors
RecruitingPhase 1
- PRISMA Health/ITOR, Greenville
A Study of DR-0202 in Patients With Locally Advanced or Metastatic, Relapsed or Refractory Carcinomas
RecruitingPhase 1
- Dren Investigational Site, Greenville
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
RecruitingObservational study
- Massive Bio SYNERGY-AI site, Greenville
Endometrial Cancer trials in other cities
- Houston, TX68 studies
- New York City, NY52 studies
- Boston, MA50 studies
- Arlington, VA39 studies
- Nashville, TN38 studies
- Los Angeles, CA34 studies
- St. Louis, MO29 studies
- Philadelphia, PA28 studies
- San Antonio, TX27 studies
- Columbus, OH25 studies
- Oklahoma City, OK25 studies
- Chicago, IL25 studies
Other studies in Greenville
- Non-Small Cell Lung Cancer15 studies
- Breast Cancer12 studies
- Acute Myeloid Leukemia10 studies
- Cancer (all types)9 studies
- Obesity9 studies
- Lung Cancer9 studies
- Overweight8 studies
- Prostate Cancer7 studies
- Colorectal Cancer7 studies
- Stomach Cancer6 studies
- Peripheral Arterial Disease5 studies
- Burkitt Lymphoma5 studies
From ClinicalTrials.gov, data retrieved Oct 6, 2026. Each study sets its own eligibility; the study team decides who can join.